Antifungal Susceptibility Testing of Candida and Cryptococcus Species and Mechanisms of Resistance: Implications for Clinical Laboratories

about

Antifungal Susceptibility Testing of Candida and Cryptococcus Species and Mechanisms of Resistance: Implications for Clinical Laboratories

Item

http://www.wikidata.org/entity/Q57745988

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2017

@uk

name

Antifungal Susceptibility Test ...... ions for Clinical Laboratories

@en

Antifungal Susceptibility Test ...... ions for Clinical Laboratories

@nl

type

Item

label

Antifungal Susceptibility Test ...... ions for Clinical Laboratories

@en

Antifungal Susceptibility Test ...... ions for Clinical Laboratories

@nl

prefLabel

Antifungal Susceptibility Test ...... ions for Clinical Laboratories

@en

Antifungal Susceptibility Test ...... ions for Clinical Laboratories

@nl

P1476

Antifungal Susceptibility Test ...... ions for Clinical Laboratories

@en

P2093

Catriona L. Halliday

http://www.w3.org/2001/XMLSchema#string

Monica A. Slavin

http://www.w3.org/2001/XMLSchema#string

Sharon C.-A. Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Global Molecular Epidemiology of Cryptococcus neoformans and Cryptococcus gattii: An Atlas of the Molecular Types

Emerging Threats in Antifungal-Resistant Fungal Pathogens

Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes

Hidden killers: human fungal infections

Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.

Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011.

Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.

Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States

In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.

Rapid quantification of drug resistance gene expression in Candida albicans by reverse transcriptase LightCycler PCR and fluorescent probe hybridization.

P2888

s12281-017-0282-9

P304

124-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12281-017-0282-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime